AADI longTrade levels are:
Entry price: $12.53
Take profit: $14.04
Stop loss: $11.96
Risk/reward: 2,65
0%
0%
0%
0%
0%
About Aadi Bioscience, Inc
Sector
Health Technology
Industry
Biotechnology
CEO
Scott M. Giacobello
Website
aadibio.com
Headquarters
Los Angeles
Employees
79
Founded
2007
ISIN
US00032Q1040
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.
AADI - DOUBLE BOTTOMpotentially a double bottom where we could bounce in one of the 2 areas - i would like to see bull divergence and accumulation before going long
Projection of this target as shown.
Finally hit Entry on $AADIAs you can see, $AADI hit on the Support line at 18.62.
I set my Targets at:
21.64
25.78
27.80
and expect a gain around 50%.
AADI Technical analyse.As you can see, $AADI is in a down Channel.
As I said before, we bounce off the channel down resistance line and will most likely touch the support line, after which we can definitely expect a breakout from the channel down. However, I am not sure if we will bounce off Resistance Line 2 or expect a
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
